Last update: July 16, 2017
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Eslicarbazepine or S-licarbazepine is the S-enantiomer of licarbazepine (MHD), the active metabolite of oxcarbazepine (see specific information), an anti-epileptic drug considered to be of low risk during breastfeeding.
Since the last update we have not found any published data on its excretion in breast milk.
Given the structural equivalence and similar actions to oxcarbazepine, different effects are not likely in infants who are breastfed by mothers undergoing treatment with eslicarbazepine or oxcarbazepine, but until there is more data on this drug in relation to breastfeeding, safer known alternatives are preferred, especially in the neonatal period and in case of prematurity.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.